Inhibition of ERK1/2 improves lipid balance in rat macrophages via ABCA1/G1 and CD36

Xue,Xie‑Hua; Shi,Feng‑Fei; Chen,Tong; Wei,Wei; Zhou,Xiao‑Mao; Chen,Li‑Dian

doi:10.3892/mmr.2015.4697

Inhibition of ERK1/2 improves lipid balance in rat macrophages via ABCA1/G1 and CD36

Authors:
- Xie‑Hua Xue
- Feng‑Fei Shi
- Tong Chen
- Wei Wei
- Xiao‑Mao Zhou
- Li‑Dian Chen
View Affiliations

Affiliations: Department of Neurology, Rehabilitation Hospital Affiliated to Fujian University of Traditional Chinese Medicine, Fuzhou, Fujian 350003, P.R. China, Institute of Rehabilitation Medicine, Rehabilitation Technology Collaborative Innovation Center, College of Rehabilitation Medicine, Fujian University of Traditional Chinese Medicine, Fuzhou, Fujian 350003, P.R. China
Published online on: December 21, 2015 https://doi.org/10.3892/mmr.2015.4697
Pages: 1533-1540

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

ATP-binding cassette transporters A1 (ABCA1) and G1 (ABCG1), and macrophage scavenger receptor, cluster of differentiation (CD)36, function as key mediators of cholesterol efflux and influx from macrophages. In addition, they are associated with foam cell formation and the development of atherosclerosis (AS). The aim of the present study was to investigate the effects of extracellular signal‑regulated kinases 1/2 (ERK1/2) inhibition on lipid balance in oxidized‑low‑density lipoprotein (Ox‑LDL)‑stimulated rat macrophages, and to examine the role of ERK1/2 inhibitors in AS. Rat peritoneal macrophages were treated with Ox‑LDL alone or in combination with an ERK1/2 inhibitor, U0126, and untreated cells served as controls. Ox‑LDL‑induced lipid accumulation was detected by DiI fluorescence and oil red O staining. In addition, the mRNA and protein expression levels of ABCA1, ABCG1 and CD36 were determined using polymerase chain reaction and western blotting, respectively. Treatment with Ox‑LDL significantly increased lipid accumulation and upregulated the mRNA and protein expression levels of ABCA1, ABCG1 and CD36 in macrophages. The addition of U0126 resulted in a marked reduction of lipid deposition, upregulation of ABCA1/G1 expression and suppression of CD36 expression in Ox‑LDL‑stimulated macrophages. The results of the present study indicated a novel association between ERK1/2 signaling and lipid metabolism, thus suggesting that inhibition of ERK1/2 may be considered a promising therapeutic strategy against AS.

View Figures

View References

1	Lusis AJ: Atherosclerosis. Nature. 407:233–241. 2000. View Article : Google Scholar : PubMed/NCBI
2	Febbraio M and Silverstein RL: CD36: Implications in cardiovascular disease. Int J Biochem Cell Biol. 39:2012–2030. 2007. View Article : Google Scholar : PubMed/NCBI
3	Rahaman SO, Lennon DJ, Febbraio M, Podrez EA, Hazen SL and Silverstein RL: A CD36-dependent signaling cascade is necessary for macrophage foam cell formation. Cell Metab. 4:211–221. 2006. View Article : Google Scholar : PubMed/NCBI
4	Roskoski RJ Jr: ERK1/2 MAP kinases: Structure, function and regulation. Pharmacol Res. 66:105–143. 2012. View Article : Google Scholar : PubMed/NCBI
5	Zhou X, Yin Z, Guo X, Hajjar DP and Han J: Inhibition of ERK1/2 and activation of liver X receptor synergistically induce macrophage ABCA1 expression and cholesterol efflux. J Biol Chem. 285:6316–6326. 2010. View Article : Google Scholar :
6	Ye D, Lammers B, Zhao Y, Meurs I, Van Berkel TJ and Van Eck M: ATP-binding cassette transporters A1 and G1, HDL metabolism, cholesterol efflux, and inflammation: Important targets for the treatment of atherosclerosis. Curr Drug Targets. 12:647–660. 2011. View Article : Google Scholar
7	Silverstein RL and Febbraio M: CD36 and atherosclerosis. Curr Opin Lipidol. 11:483–491. 2000. View Article : Google Scholar : PubMed/NCBI
8	Liu HY, Cui HB, Chen XM, Chen XY, Wang SH, Du WP, Zhou HL, Zhao RC, Zhou Y, Liu YH, et al: Imbalanced response of ATP-binding cassette transporter A1 and CD36 expression to increased oxidized low-density lipoprotein loading contributes to the development of THP-1 derived foam cells. J Biochem. 155:35–42. 2014. View Article : Google Scholar : PubMed/NCBI
9	Liu W, Jiang J, Yan D, Li D, Li W, Ma Y, Yang L, Qu Z and Ruan Q: Pentraxin 3 promotes oxLDL uptake and inhibits cholesterol efflux from macrophage-derived foam cells. Exp Mol Pathol. 96:292–299. 2014. View Article : Google Scholar : PubMed/NCBI
10	Jing Q, Xin SM, Zhang WB, Wang P, Qin YW and Pei G: Lysophosphatidylcholine activates p38 and p42/44 mitogen-activated protein kinases in monocytic THP-1 cells, but only p38 activation is involved in its stimulated chemotaxis. Circ Res. 87:52–59. 2000. View Article : Google Scholar : PubMed/NCBI
11	Cheng X, Liu X, Song L, He Y, Li X and Zhang H: Atorvastatin inhibits macrophage-derived foam cell formation by suppressing the activation of PPARγ and NF-κB pathway. Nan Fang Yi Ke Da Xue Xue Bao. 34:896–900. 2014.In Chinese. PubMed/NCBI
12	Bhandary B, Lee GH, So BO, Kim SY, Kim MG, Kwon JW, Song JY, Lee HK, Kim HR, Chae SW and Chae HJ: Rubus coreanus inhibits oxidized-LDL uptake by macrophages through regulation of JNK activation. Am J Chin Med. 40:967–978. 2012. View Article : Google Scholar : PubMed/NCBI
13	Glass CK and Witztum JL: Atherosclerosis. The road ahead Cell. 104:503–516. 2001.
14	Tiwari RL, Singh V and Barthwal MK: Macrophages: An elusive yet emerging therapeutic target of atherosclerosis. Med Res Rev. 28:483–544. 2008. View Article : Google Scholar
15	Ouimet M: Autophagy in obesity and atherosclerosis: Interrelationships between cholesterol homeostasis, lipoprotein metabolism and autophagy in macrophages and other systems. Biochim Biophys Acta. 1831:1124–1133. 2013. View Article : Google Scholar : PubMed/NCBI
16	Webb NR and Moore KJ: Macrophage-derived foam cells in atherosclerosis: Lessons from murine models and implications for therapy. Curr Drug Targets. 8:1249–1263. 2007. View Article : Google Scholar
17	Morio H, Saito H, Hirai A, Tamura Y and Yoshida S: Effect of modified LDL on the release of NO and PGI2 from rat peritoneal macrophages. J Atheroscler Thromb. 2:41–45. 1995. View Article : Google Scholar : PubMed/NCBI
18	Hirai A, Kino T, Tokinaga K, Tahara K, Tamura Y and Yoshida S: Regulation of sterol carrier protein 2 (SCP2) gene expression in rat peritoneal macrophages during foam cell formation. A key role for free cholesterol content. J Clin Invest. 94:2215–2223. 1994. View Article : Google Scholar : PubMed/NCBI
19	Nicholson AC and Hajjar DP: CD36, oxidized LDL and PPAR gamma: Pathological interactions in macrophages and atherosclerosis. Vascul Pharmacol. 41:139–146. 2004. View Article : Google Scholar : PubMed/NCBI
20	Min KJ, Um HJ, Cho KH and Kwon TK: Curcumin inhibits oxLDL-induced CD36 expression and foam cell formation through the inhibition of p38 MAPK phosphorylation. Food Chem Toxicol. 58:77–85. 2013. View Article : Google Scholar : PubMed/NCBI
21	Febbraio M, Podrez EA, Smith JD, Hajjar DP, Hazen SL, Hoff HF, Sharma K and Silverstein RL: Targeted disruption of the class B scavenger receptor CD36 protects against atherosclerotic lesion development in mice. J Clin Invest. 105:1049–1056. 2000. View Article : Google Scholar : PubMed/NCBI
22	Febbraio M, Guy E and Silverstein RL: Stem cell transplantation reveals that absence of macrophage CD36 is protective against atherosclerosis. Arterioscler Thromb Vasc Biol. 24:2333–2338. 2004. View Article : Google Scholar : PubMed/NCBI
23	Marleau S, Harb D, Bujold K, Avallone R, Iken K, Wang Y, Demers A, Sirois MG, Febbraio M, Silverstein RL, et al: EP 80317, a ligand of the CD36 scavenger receptor, protects apolipoprotein E-deficient mice from developing atherosclerotic lesions. FASEB J. 19:1869–1871. 2005.PubMed/NCBI
24	Zhao M, Liu Y, Wang X, New L, Han J and Brunk UT: Activation of the p38 MAP kinase pathway is required for foam cell formation from macrophages exposed to oxidized LDL. APMIS. 110:458–468. 2002. View Article : Google Scholar : PubMed/NCBI
25	Wang N, Lan D, Chen W, Matsuura F and Tall AR: ATP-binding cassette transporters G1 and G4 mediate cellular cholesterol efflux to high-density lipoproteins. Proc Natl Acad Sci USA. 101:9774–9779. 2004. View Article : Google Scholar : PubMed/NCBI
26	Wang N, Silver DL, Costet P and Tall AR: Specific binding of ApoA-I, enhanced cholesterol efflux, and altered plasma membrane morphology in cells expressing ABC1. J Biol Chem. 275:33053–33058. 2000. View Article : Google Scholar : PubMed/NCBI
27	Tang CK, Yi GH, Yang JH, Liu LS, Wang Z, Ruan CG and Yang YZ: Oxidized LDL upregulated ATP binding cassette transporter-1 in THP-1 macrophages. Acta Pharmacol Sin. 25:581–586. 2004.PubMed/NCBI
28	Chang YC, Sheu WH, Chien YS, Tseng PC, Lee WJ and Chiang AN: Hyperglycemia accelerates ATP-binding cassette transporter A1 degradation via an ERK-dependent pathway in macrophages. J Cell Biochem. 114:1364–1373. 2013. View Article : Google Scholar
29	Mulay V, Wood P, Manetsch M, Darabi M, Cairns R, Hoque M, Chan KC, Reverter M, Alvarez-Guaita A, Rye KA, et al: Inhibition of mitogen-activated protein kinase Erk1/2 promotes protein degradation of ATP binding cassette transporters A1 and G1 in CHO and HuH7 cells. PLoS One. 8:e626672013. View Article : Google Scholar : PubMed/NCBI
30	Hao XR, Cao DL, Hu YW, Li XX, Liu XH, Xiao J, Liao DF, Xiang J and Tang CK: IFN-gamma down-regulates ABCA1 expression by inhibiting LXRalpha in a JAK/STAT signaling pathway-dependent manner. Atherosclerosis. 203:417–428. 2009. View Article : Google Scholar
31	Chen M, Li W, Wang N, Zhu Y and Wang X: ROS and NF-kappaB but not LXR mediate IL-1beta signaling for the downregulation of ATP-binding cassette transporter A1. Am J Physiol Cell Physiol. 292:C1493–C1501. 2007. View Article : Google Scholar
32	Uehara Y, Miura S, von Eckardstein A, Abe S, Fujii A, Matsuo Y, Rust S, Lorkowski S, Assmann G, Yamada T and Saku K: Unsaturated fatty acids suppress the expression of the ATP-binding cassette transporter G1 (ABCG1) and ABCA1 genes via an LXR/RXR responsive element. Atherosclerosis. 191:11–21. 2007. View Article : Google Scholar
33	Nagelin MH, Srinivasan S, Lee J, Nadler JL and Hedrick CC: 12/15-Lipoxygenase activity increases the degradation of macrophage ATP-binding cassette transporter G1. Arterioscler Thromb Vasc Biol. 28:1811–1819. 2008. View Article : Google Scholar : PubMed/NCBI
34	Yang C, Cui K, Diao Y, Du M and Wang S: Effect of selenium-enriched garlic pil against cytotoxicity induced by OX-LDL in endothelial cells. Evid Based Complement Alternat Med. 2014:5376522014. View Article : Google Scholar
35	Xue X, Chen T, Wei W, Zhou X, Lin Z and Chen L: Effects of Alisma Decoction on lipid metabolism and inflammatory response are mediated through the activation of the LXRα pathway in macrophage-derived foam cells. Int J Mol Med. 33:971–977. 2014.PubMed/NCBI
36	Tang SL, Chen WJ, Yin K, Zhao GJ, Mo ZC, Lv YC, Ouyang XP, Yu XH, Kuang HJ, Jiang ZS, et al: PAPP-A negatively regulates ABCA1, ABCG1 and SR-B1 expression by inhibiting LXRα through the IGF-I-mediated signaling pathway. Atherosclerosis. 222:344–354. 2012. View Article : Google Scholar : PubMed/NCBI
37	Ma AZ, Song ZY and Zhang Q: Cholesterol efflux is LXRα isoform-dependent in human macrophages. BMC Cardiovasc Disord. 14:802014. View Article : Google Scholar
38	Bhatt KH, Sodhi A and Chakraborty R: Peptidoglycan induced expression of peroxisome proliferator-activated receptor γ in mouse peritoneal macrophages: Role of ERK and JNK MAP kinases. Cytokine. 60:778–786. 2012. View Article : Google Scholar : PubMed/NCBI
39	Stachowska E, Kijowski J, Dziedziejko V, Siennicka A and Chlubek D: Conjugated linoleic acid regulates phosphorylation of PPARγ by modulation of ERK 1/2 and p38 signaling in human macrophages/fatty acid-laden macrophages. J Agric Food Chem. 59:11846–11852. 2011. View Article : Google Scholar : PubMed/NCBI
40	Mogilenko DA, Shavva VS, Dizhe EB, Orlov SV and Perevozchikov AP: PPARγ activates ABCA1 gene transcription but reduces the level of ABCA1 protein in HepG2 cells. Biochem Biophys Res Commun. 402:477–482. 2010. View Article : Google Scholar : PubMed/NCBI